Novartis has announced positive findings from its the Phase 3 trial assessing the efficacy and safety of Beovu (brolucizumab) to...
Read moreRetina Australia has awarded a total of $160,000 in study grants to some of the biggest names in Australian retinal...
Read moreGlaukos has unveiled a new single-use surgical gonioscopy lens that is said to provide exceptional clarity with expanded views of...
Read moreMedicinal cannabis is often presented as an alternative treatment for glaucoma. Although there is evidence that cannabis lowers intraocular pressure,...
Read moreProfessor Robyn Guymer has led an expert panel to update RANZCO’s Referral Pathway for Age-Related Macular Degeneration (AMD) Management, which...
Read moreThe world’s largest childhood myopia education resource developed by Australian optometry couple Dr Kate and Dr Paul Gifford has formed...
Read moreMelbourne biopharmaceutical company Opthea has received an $8.5 million research and development (R&D) tax credit from the Australian tax authority...
Read moreA Victorian biopharmaceutical company has reported positive results from a Phase 1 study examining the safety of its biodegradable implant...
Read moreBausch + Lomb has acquired an exclusive license for a novel myopia control contact lens developed by a Sydney ophthalmic...
Read moreAustralian of the Year and ophthalmologist Dr James Muecke has endorsed a new campaign aimed at motivating Australians in their...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited